Last reviewed · How we verify
NCT04252027
Therapeutic Drug Monitoring of Fluconazole in Critically Ill Patients
trial testing Sample collection in Critically Ill Patients in 43 participants. Completed in 5 March 2020.
5 March 2020
Quick facts
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 23 April 2019 |
| Primary completion | 5 March 2020 |
| Estimated completion | 5 March 2020 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Sample collection — full drug profile →
Conditions studied
- Critically Ill Patients — all drugs for Critically Ill Patients →
Sponsor
Universitaire Ziekenhuizen KU Leuven — full company profile →
Who can join
18 and older, any sex, with Critically Ill Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective study will research the exposure and its variability to fluconazole after longitudinal administration in critically ill patients
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients.
Van Daele R, Wauters J, Lagrou K, Denooz R, et al · · 2021 · cited 17× · PMID 34683388 · DOI 10.3390/microorganisms9102068
Verify or expand the search:
- PubMed search for NCT04252027
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sample collection
Trials testing the same drug.
- NCT06634160 — Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozyg · recruiting
- NCT04894370 — Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma · Phase 2 · recruiting
- NCT06820151 — Exploring the Landscape of Injury and Repair in the Human Oesophagus · enrolling by invitation
- NCT05937815 — Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor · NA · unknown
- NCT05462366 — Omics Sequencing of Specimen Derived From Mother-Infant-Pairs · recruiting
Other recruiting trials for Critically Ill Patients
Currently open trials in the same condition.
- NCT07124442 — Disease Severity, Mortality Risk, and Muscle Function in Intensive Care Unit Patients · recruiting
- NCT06486467 — Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI · NA · recruiting
- NCT06109142 — Clearance of Vasoactive Metabolites With Blood Purification · recruiting
- NCT06543602 — the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave · recruiting
- NCT06234787 — Continuous Subcutaneous Glucose Monitoring in Critical Patients · recruiting
Other Universitaire Ziekenhuizen KU Leuven trials
Trials by the same sponsor.
- NCT06831955 — LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer · Phase 2 · recruiting
- NCT07356505 — Efficacy and Safety of Micra AV2 Transcatheter Pacing System · NA · recruiting
- NCT07286968 — Gastro-Intestinal Digestion and Physiology After Bariatric Surgery · recruiting
- NCT06962137 — Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer · Phase 2 · recruiting
- NCT07270536 — Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04252027 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitaire Ziekenhuizen KU Leuven
- Last refreshed: 28 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04252027.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing